Table 2.

Reports involving 10 or more patients treated with rituximab in the acute phase of autoimmune TTP: outcome

Reports involving 10 or more patients treated with rituximab in the acute phase of autoimmune TTP: outcome

RFS indicates relapse-free survival; and VZV, varicella zoster virus.

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal